Adjuvant sorafenib for liver cancer: wrong stage, wrong dose

Lancet Oncol. 2015 Oct;16(13):1279-81. doi: 10.1016/S1470-2045(15)00296-X.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / surgery*
  • Catheter Ablation*
  • Female
  • Hepatectomy*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / surgery*
  • Male
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Niacinamide